Valuation: IRIDEX Corporation

Market Cap 15.51M 13.62M 12.67M 11.62M 21.84M 1.49B 22.17M 150M 58.76M 734M 58.21M 56.95M 2.54B P/E 2026 *
-17.8x
P/E 2027 * 44.5x
Enterprise Value 15.51M 13.62M 12.67M 11.62M 21.84M 1.49B 22.17M 150M 58.76M 734M 58.21M 56.95M 2.54B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.27x
Free-Float
62.93%
Yield 2026 *
-
Yield 2027 * -
1 day-3.38%
1 week-4.67%
Current month-22.20%
1 month-24.51%
3 months-15.96%
6 months-41.39%
Current year-21.86%
1 week 0.88
Extreme 0.88
0.94
1 month 0.88
Extreme 0.88
1.19
Current year 0.88
Extreme 0.88
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.51
Manager TitleAgeSince
Chief Executive Officer 54 01/10/2024
Director of Finance/CFO 68 18/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 24/06/2020
Director/Board Member 54 01/09/2018
Director/Board Member 66 17/03/2022
Date Insider Type Main position Quantity % Market Cap.
10/07/26 Free

Chief Executive Officer

400,000 2.2980%
10/07/26 Free

Chief Financial Officer

200,000 1.1490%
13/06/26 Tax

Chief Executive Officer

-3,990 0.0229%
Change 5-day change 1-year change 3-year change Capi.($)
-3.38%-4.67%-36.82%-56.76% 15.51M
-0.71%+6.72%+18.80%-0.46% 211B
-0.52%-6.05%-6.80%-25.11% 135B
+1.65%-2.29%-31.94%+1.99% 119B
+1.54%+0.50%-58.31%-15.57% 65.77B
-1.42%-3.62%+3.29%-9.87% 47.58B
+3.03%-0.17%-26.91%-33.60% 44.44B
-0.84%+5.41%+15.30%+8.84% 39.14B
-2.02%+1.54%+23.68%+30.76% 36.79B
-1.41%+3.99%+77.58%+2.50% 29.37B
Average -0.41%-0.04%-2.21%-9.73% 72.81B
Weighted average by Cap. -0.00%+0.37%-2.58%-6.42%

Financials

2026 *2027 *
Net sales 53M 46.55M 43.29M 39.72M 74.64M 5.1B 75.79M 514M 201M 2.51B 199M 195M 8.68B 56.77M 49.86M 46.37M 42.55M 79.94M 5.47B 81.18M 551M 215M 2.69B 213M 209M 9.29B
Net income -795K -698K -649K -596K -1.12M -76.56M -1.14M -7.71M -3.01M -37.64M -2.98M -2.92M -130M 361K 317K 295K 271K 508K 34.76M 516K 3.5M 1.37M 17.09M 1.36M 1.33M 59.09M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
24/07/26 $0.8908 -3.38% 30,839
23/07/26 $0.9220 +0.75% 26,390
22/07/26 $0.9151 0.00% 18,730
21/07/26 $0.9151 -1.13% 40,339
20/07/26 $0.9256 -0.94% 57,581
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8908USD
Average target price
2.750USD
Spread / Average Target
+208.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock